Tower Research Capital (TRC)’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.6K Buy
6,460
+4,765
+281% +$39.6K ﹤0.01% 2916
2025
Q1
$10.3K Sell
1,695
-501
-23% -$3.05K ﹤0.01% 3652
2024
Q4
$13.9K Sell
2,196
-253
-10% -$1.6K ﹤0.01% 3499
2024
Q3
$12.2K Sell
2,449
-2,098
-46% -$10.5K ﹤0.01% 3607
2024
Q2
$27.8K Buy
4,547
+4,157
+1,066% +$25.4K ﹤0.01% 3547
2024
Q1
$4.34K Sell
390
-2,658
-87% -$29.6K ﹤0.01% 4692
2023
Q4
$34.2K Buy
3,048
+1,578
+107% +$17.7K ﹤0.01% 3351
2023
Q3
$11K Buy
1,470
+844
+135% +$6.34K ﹤0.01% 4042
2023
Q2
$5.53K Sell
626
-2,492
-80% -$22K ﹤0.01% 4797
2023
Q1
$26K Buy
3,118
+26
+0.8% +$217 ﹤0.01% 3150
2022
Q4
$29K Sell
3,092
-519
-14% -$4.87K ﹤0.01% 2772
2022
Q3
$29K Sell
3,611
-366
-9% -$2.94K ﹤0.01% 3620
2022
Q2
$23K Buy
3,977
+3,839
+2,782% +$22.2K ﹤0.01% 3642
2022
Q1
$1K Sell
138
-5,832
-98% -$42.3K ﹤0.01% 5779
2021
Q4
$26K Buy
+5,970
New +$26K ﹤0.01% 3382
2021
Q2
Sell
-5,075
Closed -$31K 5571
2021
Q1
$31K Buy
5,075
+205
+4% +$1.25K ﹤0.01% 3537
2020
Q4
$36K Sell
4,870
-15,937
-77% -$118K ﹤0.01% 3421
2020
Q3
$126K Buy
20,807
+19,631
+1,669% +$119K ﹤0.01% 2953
2020
Q2
$10K Buy
+1,176
New +$10K ﹤0.01% 4005
2020
Q1
Sell
-1,163
Closed -$7K 3290
2019
Q4
$7K Buy
1,163
+753
+184% +$4.53K ﹤0.01% 2508
2019
Q3
$2K Buy
+410
New +$2K ﹤0.01% 3679
2019
Q2
Sell
-3,512
Closed -$17K 3869
2019
Q1
$17K Buy
+3,512
New +$17K ﹤0.01% 2358
2018
Q4
Sell
-311
Closed -$3K 3963
2018
Q3
$3K Buy
+311
New +$3K ﹤0.01% 3300
2018
Q2
Sell
-82
Closed -$1K 3766
2018
Q1
$1K Sell
82
-1,009
-92% -$12.3K ﹤0.01% 3063
2017
Q4
$14K Buy
1,091
+691
+173% +$8.87K ﹤0.01% 2314
2017
Q3
$4K Buy
+400
New +$4K ﹤0.01% 3389